Oligonucleotide-Induced Myoblast Differentiation via Map4k4 Suppression
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for inducing muscle differentiation and treating muscle disorders are inadequate, as they fail to effectively regulate the expression of key proteins involved in myogenesis, such as Map4k4, which is crucial for muscle fiber formation and function.
Innovation Solution
The use of oligonucleotides, specifically inhibitory RNA, antisense oligonucleotides, and ribozymes, that decrease Map4k4 mRNA expression in myoblasts and myocytes to promote differentiation into myotubes and treat muscle disorders by increasing the expression of myogenic regulatory factors like Myf5 and creatine kinase.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If current methods are used to induce muscle differentiation, then muscle fiber formation occurs, but the expression of key proteins like Map4k4 is not effectively regulated
Solution Approach 1:
The patent extracts and targets the specific Map4k4 gene sequence using oligonucleotides (siRNA, antisense oligonucleotides, or ribozymes) to selectively decrease Map4k4 mRNA expression. This extraction approach allows precise regulation of the problematic gene without affecting other muscle differentiation genes, thereby improving both regulation precision and differentiation effectiveness
Solution Approach 2:
The patent changes the expression level parameter of Map4k4 by introducing oligonucleotides that specifically target and decrease Map4k4 mRNA. This parameter change (reducing Map4k4 expression) resolves the contradiction by enabling effective muscle differentiation while achieving precise regulation of the key protein expression
2Productivity
If Map4k4 expression is not regulated, then muscle differentiation proceeds, but muscle mass increase and treatment outcomes are limited
Solution Approach 1:
The patent implements a feedback mechanism where oligonucleotides are designed to respond to and regulate Map4k4 expression levels. By decreasing Map4k4 mRNA expression, the system creates a feedback loop that enhances the expression of myogenic regulatory factors (Myf5, MyoD, myogenin, MRF4) and promotes more efficient muscle differentiation and myotube formation, thereby increasing muscle mass formation rate with improved control precision
Solution Approach 2:
The oligonucleotides act as intermediary molecules that mediate between the Map4k4 gene and the muscle differentiation process. These intermediaries (siRNA, antisense oligonucleotides, or ribozymes) specifically bind to Map4k4 mRNA to decrease its expression, thereby indirectly enhancing the expression of myogenic regulatory factors and improving both productivity and control precision in muscle mass formation
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enhances muscle differentiation and formation, leading to increased muscle mass and improved treatment outcomes for muscle disorders by reducing Map4k4 expression and promoting the expression of key muscle-specific proteins.
Implementation Method 1
oligonucleotides that decrease the expression of Mitogen-activated protein kinase kinase kinase kinase 4 (Map4k4) mRNA in a myoblast or myocyte
Implementation Method 2
an inhibitory RNA, an antisense oligonucleotide, and a ribozyme that decreases Map4k4 mRNA expression
Data Source
AI summary
Provided herein are methods of inducing differentiation of a mammalian myoblast into a mammalian myocyte that include contacting a mammalian myoblast with an oligonucleotide that decreases Mitogen-activated protein kinase kinase kinase kinase 4 (Map4k4) mRNA expression in a mammalian myoblast or myocyte. Also provided are methods of inducing mammalian myoblasts or myocytes to form a myotube that include contacting two or more mammalian myoblasts or two or more mammalian myocytes with an oligonucleotide that decreases Map4k4 mRNA expression in a mammalian myoblast or myocyte. Also provided are methods of identifying a candidate agent useful for inducing muscle formation, and compositions containing an oligonucleotide that decreases Map4k4 mRNA expression in mammalian myoblast or myocyte and one or more additional muscle therapeutic agents and/or muscle-building neutraceuticals.